ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

TERN Terns Pharmaceuticals Inc

5.44
0.15 (2.84%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Terns Pharmaceuticals Inc TERN 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.15 2.84% 5.44 13:00:02
개장가 저가 고가 종가 전일 종가
5.39 5.21 5.57 5.44 5.29
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
04/05/202405:05GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
30/04/202405:05GLOBETerns Pharmaceuticals Announces Data from Ongoing Phase 1..
11/04/202405:05GLOBETerns Pharmaceuticals Appoints Melita Sun Jung as Chief..
15/03/202405:05GLOBETerns Pharmaceuticals Reports Fourth Quarter and Full Year..
12/03/202405:05GLOBETerns Pharmaceuticals Announces Orphan Drug Designation..
08/03/202406:05GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
06/03/202408:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202406:05GLOBETerns Pharmaceuticals to Participate in Upcoming March..
16/02/202408:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/02/202422:57EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/02/202406:20EDGAR2Form 8-K - Current report
08/02/202406:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New Chief..
07/02/202422:05GLOBETerns Pharmaceuticals Appoints Amy Burroughs as Chief..
03/02/202406:05GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
26/01/202409:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202406:05GLOBETerns Pharmaceuticals to Highlight 2024 Priorities and..
04/01/202406:05GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
30/11/202306:05GLOBETerns Pharmaceuticals to Present at the JMP Securities..
28/11/202306:05GLOBETerns Pharmaceuticals Mourns the Loss of Senthil Sundaram,..
14/11/202322:05GLOBETerns Pharmaceuticals Reports Third Quarter 2023 Financial..
13/11/202322:05GLOBETerns Pharmaceuticals Presents Late-Breaking Data from Phase..
09/11/202322:05GLOBETerns Pharmaceuticals to Participate in Upcoming November..
04/11/202305:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
03/11/202305:05GLOBETerns Pharmaceuticals Announces First Participant Dosed in..
20/10/202305:05GLOBETerns Pharmaceuticals to Participate in Upcoming Investor..
16/10/202321:05GLOBETerns Pharmaceuticals Announces Global Phase 1 Clinical..
11/10/202305:33EDGAR2Form 8-K - Current report
04/10/202305:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
07/09/202305:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
06/09/202305:05GLOBETerns Pharmaceuticals to Participate in Upcoming September..
09/08/202305:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/08/202305:24EDGAR2Form 8-K - Current report
09/08/202305:15GLOBETerns Pharmaceuticals Reports Second Quarter 2023 Financial..
09/08/202305:05GLOBETerns Achieves Primary Endpoint and All Secondary Endpoints..
04/08/202307:00GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
04/08/202306:22EDGAR2Form 8-K - Current report
04/08/202306:05GLOBETerns Pharmaceuticals Announces Leadership Transition
19/07/202305:05GLOBETerns Pharmaceuticals to Host Virtual Key Opinion Leader..
06/07/202305:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
27/06/202305:05GLOBETerns Pharmaceuticals Highlights New Preclinical Data for..
07/06/202305:30GLOBETerns Pharmaceuticals to Present at Goldman Sachs 44th..
03/06/202305:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
26/05/202306:05GLOBETerns Pharmaceuticals Announces Publication of TERN-701..
25/05/202305:05GLOBETerns Pharmaceuticals to Present at Upcoming Investor..
23/05/202305:05GLOBETerns Pharmaceuticals to Highlight New Preclinical Data for..
15/05/202321:05GLOBETerns Pharmaceuticals Reports First Quarter 2023 Financial..
10/05/202305:05GLOBETerns Pharmaceuticals to Participate in the JMP Securities..

최근 히스토리

Delayed Upgrade Clock